期刊文献+

宫颈癌新辅助化疗32例临床分析

Clinical observation of neoadjuvant chemotherapy based on carboplatin for 32 cases of cervical cancer
下载PDF
导出
摘要 目的分析评价以卡铂为基础的宫颈癌新辅助化疗的疗效和毒副作用。方法对该院收治的32例初治宫颈癌患者,以卡铂+5氟脲嘧啶(5-Fu)方案进行单疗程新辅助化疗。结果临床CR与PR总有效率为75%;症状缓解方面,显效率81.3%。骨髓抑制是本次化疗方案显著的毒副作用。结论 NACT是有效的;但是仍然需要进一步研究。 Objective From efficacy and safety,the carboplatin neoadjuvant chemotherapy is evaluated. Methods Our hospital has treated 32 untreated cervical cancer by single cycle of carboplatin NACT. Results The overall rate of the complete and partial response was 75%. From the aspect of Symptoms,the remarkable efficiency was 81.3%. Bone marrow suppression is the bad effects. Conclusion NACT is effective,but it needs further study.
作者 赵宁
出处 《中国卫生产业》 2013年第20期1-1,3,共2页 China Health Industry
关键词 宫颈癌 新辅助化疗 疗效 副作用 Cervical cancer NACT Efficacy Side effect
  • 相关文献

参考文献4

  • 1WTO.A guide to essential practice[R].Word Health Organization Web site (2006). [2008-02-06].
  • 2Petterson F.Annnal report on the results of treatment in gynecological cancer[J]. Stockholm FIGO, 1992 (21) : 38-40.
  • 3马玉英,王伟,陈素琼.宫颈癌新辅助化疗54例临床分析[J].现代肿瘤医学,2009,17(9):1760-1761. 被引量:10
  • 4Frei E. An embattled species[J]. Clinical cancer research, 1982, 50: 1979-1992.

二级参考文献5

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部